• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Holdings
Company Encyclopedia
View More
name
CAM HSBIOTECH
03069.HK
Shareholder
Ownership%OwnedShare ChgReport Date
No Data
News
View More

In the Hong Kong stock market, the Hang Seng Index rose 165 points in the first half of the day, HSBC repeatedly hit new highs, and WuXi Biologics increased by over 6%

The Hong Kong Hang Seng Index rose 165 points in the first half of the day, with HSBC repeatedly hitting new highs and WuXi Biologics up over 6%. The Bank of Japan raised interest rates by 25 basis points to 0.75%, the highest in thirty years. The U.S. core CPI hit a low, and the market anticipates the Federal Reserve will cut interest rates. The Hang Seng Index opened up 136 points and closed up 165 points at 25,663 points. The National Index rose 44 points, and the Hang Seng Tech Index rose 61 points. TikTok and Oracle formed a joint venture in the U.S. Tech stocks generally rose, and financial stocks saw HSBC reach an all-time high

AASTOCKS·6 Hours ago
US
HSBC
+0.87%
HK
00005
+0.51%
US
WXXWY
+2.45%
AASTOCKS·6 Hours ago
US
HSBC
+0.87%
HK
00005
+0.51%
US
WXXWY
+2.45%
© 2025 Longbridge|Disclaimer

Schedules & Filings

Schedules
Filings
Dec31
Distribution Plan(CST)

Cash dividend 0.05

Dec19
Distribution Plan(CST)

Cash dividend 0.05

Dec18
Distribution Plan(CST)

Cash dividend 0.05

View More

Event Tracking

Dec19
WuXi Biologics Receives CDP Climate Change and Water Security 'A' Rating
04:26
JPMorgan Sees Opportunities in China's Healthcare Sector, Recommends Biotech and CXO Stocks
02:54
Dec18
Sukoddju Injection Phase III Clinical Trial Achieves Positive Results for Severe Plaque Psoriasis Treatment
10:20
WuXi Biologics Shareholders Reduce Holdings, Stake Drops to 16.97%
09:47
WuXi Lux Holding Subsidiary Acquires Fund Investment and Transfers Shares
09:23
Dec17
JPMorgan Increases Its Stake in WuXi Biologics by 872,123 Shares
11:20